DescriptionNews release announcing that researchers at the University of Maryland School of Medicine (UMSOM) have begun testing an experimental stem cell therapy developed by Mesoblast Limited to treat hospitalized COVID-19 patients with moderate to severe acute respiratory distress syndrome (ARDS) who are on ventilators to help them breathe. Additional information available via the accompanying video.
KeywordCoronavirus Disease 2019 (COVID-19)
University of Maryland, Baltimore
University of Maryland Medical Center
Stem Cell Research